share_log

AbbVie(ABBV.US)下調第二季度及全年度盈測

AbbVie (ABBV.US) has lowered its second quarter and full-year earnings forecasts.

AASTOCKS ·  Jul 4 08:18

Regulatory documents show that US pharmaceutical company AbbVie (ABBV.US) lowered its adjusted earnings per share forecast for the full year to $10.61-$10.81, down from the previous forecast of $11.13-$11.33, while analysts expect it to be $11.25.

AbbVie also lowered its adjusted earnings per share forecast for the second quarter from $3.05-$3.09 to $2.53-$2.57 due to expenses related to $937 million in asset acquisitions, cooperation, licensing agreements, and other related expenses incurred during the quarter.

AbbVie is scheduled to announce its second-quarter earnings on July 25th.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment